Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Lancet. Diabetes & Endocrinology|September 8, 2022
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCTRaul D Santos, Andrea Ruzza, G Kees Hovingh, et al.
JAMA|March 28, 2026
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV TrialNicholas A Marston, Erin A Bohula, Ajay K Bhatia, et al.
The New England Journal of Medicine|November 10, 2025
Evolocumab in Patients without a Previous Myocardial Infarction or StrokeErin A Bohula, Nicholas A Marston, Ajay K Bhatia, et al.
Diabetes Care|June 7, 2026
Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV TrialLawrence A Leiter, Robert P Giugliano, Nicholas A Marston, et al.
Circulation|May 19, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV TrialBrian A Bergmark, Erin A Bohula, Nicholas A Marston, et al.
Pageof 2